Search Results - "Ryland, Katherine Elizabeth"

Real-World Treatment Patterns, Overall Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients with Mantle Cell Lymphoma (MCL) after Failure of Covalent Btki Treatment by Squires, Patrick, Puckett, Justin T., Ryland, Katherine Elizabeth, Kamal-Bahl, Sachin, Raut, Monika, Doshi, Jalpa A., Huntington, Scott F.

“…Background: Over the past decade, Bruton's tyrosine kinase inhibitors (BTKis) have emerged as standard of care treatment for relapsed/refractory mantle cell…”
Get full text

Assessing the Epidemiology, Treatment Patterns, and Economic Impact of Marginal Zone Lymphoma: A Review of the Literature by Squires, Patrick, Saini, Priyanka, Pandey, Prabhakar, Pandey, Rishabh, Hall, Adam, Ryland, Katherine Elizabeth, Raut, Monika, Prescott, Jennifer

Get full text

Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL) by Garg, Mahek, Huntington, Scott F., Puckett, Justin, Kamal-Bahl, Sachin, Raut, Monika, Ryland, Katherine Elizabeth, Doshi, Jalpa

Get full text

A Structured Literature Review Investigating the Current Treatment Landscape in Patients with Richter's Transformation (2011-2021) by Prescott, Jennifer, Pandey, Prabhakar, Hall, Adam, Nathani, Jyothsna, Pandey, Rishabh, Ryland, Katherine Elizabeth, Raut, Monika, Squires, Patrick

Get full text

Diffuse Large B-Cell Lymphoma (DLBCL): A Structured Literature Review of the Epidemiology, Treatment Guidelines, and Real-World Treatment Patterns by Garg, Mahek, Takyar, Jitender, Dhawan, Arju, Saggu, Gurkiran, Agrawal, Neha, Hall, Adam, Raut, Monika, Ryland, Katherine Elizabeth

Get full text

Treatment Utilization Patterns, Health Resource Use, Costs, and Survival in Mantle Cell Lymphoma: A Real-World Analysis of a National Sample of Medicare Beneficiaries by Squires, Patrick, Huntington, Scott F., Puckett, Justin, Ryland, Katherine Elizabeth, Kamal-Bahl, Sachin, Raut, Monika, Doshi, Jalpa

Get full text

Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis by Garg, Mahek, Satija, Ambika, Song, Yan, Sarpong, Eric, Meade, Ben, Lemus-Wirtz, Esteban, Gaburo, Katherine, Signorovitch, James E., Raut, Monika, Ryland, Katherine Elizabeth, Chakraborty, Samhita

Get full text

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data by Garg, Mahek, Satija, Ambika, Song, Yan, Sarpong, Eric, Meade, Ben, Lemus-Wirtz, Esteban, Gaburo, Katherine, Signorovitch, James E., Raut, Monika, Ryland, Katherine Elizabeth, Chakraborty, Samhita

Get full text

Real-World Analysis of Adverse Event Rates after Initiation of Ibrutinib Among Medicare Beneficiaries with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia By Ibrutinib Discontinuation Status by De Nigris, Enrico, Huntington, Scott F., Puckett, Justin, Kamal-Bahl, Sachin, Farooqui, Mohammed Z.H., Ryland, Katherine Elizabeth, Sarpong, Eric, Yang, Xiaoqin, Doshi, Jalpa

Get full text

Real-World Treatment Patterns and Outcomes after Ibrutinib Discontinuation Among Elderly Medicare Beneficiaries with Chronic Lymphocytic Leukemia: An Observational Study by Huntington, Scott F., De Nigris, Enrico, Puckett, Justin, Kamal-Bahl, Sachin, Farooqui, Mohammed Z.H., Ryland, Katherine Elizabeth, Sarpong, Eric, Yang, Xiaoqin, Doshi, Jalpa

Get full text

Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis by Squires, Patrick, Puckett, Justin, Ryland, Katherine Elizabeth, Kamal-Bahl, Sachin, Raut, Monika, Doshi, Jalpa, Huntington, Scott F.

“…While covalent Bruton's tyrosine kinase inhibitors (cBTKis) have become a standard of care treatment for relapsed/refractory mantle cell lymphoma (R/R MCL),…”
Get full text

Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and costs by Squires, Patrick, Puckett, Justin, Ryland, Katherine Elizabeth, Kamal-Bahl, Sachin, Raut, Monika, Doshi, Jalpa A., Huntington, Scott F.

“…Studies evaluating real-world outcomes and health care utilization for mantle cell lymphoma are limited. We utilized national Medicare claims (2009-2019) to…”
Get full text

Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma by Garg, Mahek, Puckett, Justin, Kamal-Bahl, Sachin, Raut, Monika, Ryland, Katherine Elizabeth, Doshi, Jalpa A, Huntington, Scott F

“…To examine real-world treatment patterns, survival, healthcare resource use and costs in elderly Medicare beneficiaries with diffuse large B-cell lymphoma…”
Get more information

Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting by Garg, Mahek, Puckett, Justin, Kamal-Bahl, Sachin, Raut, Monika, Ryland, Katherine Elizabeth, Doshi, Jalpa A., Huntington, Scott F.

“…Little recent real-world evidence exists on overall survival, healthcare resource utilization (HCRU), and costs among R/R DLBCL patients treated with the…”
Get full text

Keynote-B68: Updated Efficacy and Safety of Pembrolizumab Every Six Weeks in Relapsed/Refractory Classical Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma by McDonald, Andrew Bruce, Verburgh, Estelle, Gotti, Manuel, Pinto, Antonio, Zaucha, Jan Maciej, Ivanov, Vladimir, Melnichenko, Vladimir, Mocikova, Heidi, Ozcan, Muhit, Patti, Caterina, Farias, João, Goncalves, Iara Zapparoli, Kuchkova, Olha, Mayer, Jiří, Saydam, Güray, Tomassetti, Sarah, Pathiraja, Kumudu, Ryland, Katherine Elizabeth, Marinello, Patricia, Jurczak, Wojciech

“…Background: Pembrolizumab 200 mg Q3W demonstrated robust antitumor activity and manageable safety in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL)…”
Get full text